Diagnostics of Scaphoid Fractures With HRpQCT
1 other identifier
interventional
75
1 country
1
Brief Summary
The scaphoid bone is the most common fractured carpal bone. Scaphoid fractures represent 2-6% of all fractures and occur mainly in young, active patients aged 15 to 40. The scaphoid bone has an essential role in functionality of the wrist, acting as a pivot. Correct treatment of a scaphoid fracture depends on accurate and timely diagnosis, and inadequate treatment can result in avascular necrosis (up to 40%), nonunion (5-21%) and early osteoarthritis (up to 32%) that may seriously impair wrist function. In addition, impaired consolidation of scaphoid fractures results in longer immobilization leading to significant functional and psychosocial impairment thus having considerable socio-economic consequences and negative impact on the quality of life. Current diagnostic pathways can take up to two weeks to diagnose (or exclude) a scaphoid fracture, leading to overtreatment in patients with a suspected scaphoid fracture since only 15 to 30% of suspected scaphoid fractures in the Netherlands annually is found to be an actual fracture. Thus, there is significant room for improvement in the diagnostic pathway of scaphoid fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2017
CompletedFirst Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
April 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2020
CompletedApril 2, 2019
March 1, 2019
2 years
December 20, 2017
March 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scaphoid fracture detected on CT or HRpQCT
Scaphoid fracture detected on CT or HRpQCT, fracture on one of both scans is considered as a scaphoid fracture
within 10 days after presentation at the emergency department
Secondary Outcomes (4)
Fracture healing using bone parameters of the HRpQCT
untill 26weeks after fracture
Early change in bone strength as a predictive value for long term (26weeks) functional outcome
untill 26weeks after fracture
Early change in trabecular structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
untill 26weeks after fracture
Early change in cortical structure parameters measured by HRpQCT as a predictive value for long term functional outcome (26weeks)
untill 26weeks after fracture
Study Arms (1)
Suspected scaphoid fracture
OTHERPatients with a suspected scaphoid fracture
Interventions
CT = computed tomography of the hand/wrist HRpQCT = high resolution peripheral quantitative CT scan of the hand/wrist
Eligibility Criteria
You may qualify if:
- In order to be eligible to participate in Phase I of the study, a subject must meet all of the following criteria:
- Adults (18 years or older) who visit the emergency department of the VieCuri Medical Center Venlo with a clinically suspected scaphoid fracture due to a trauma (\<1 week after trauma).
- Patients who understand the conditions of the study and are willing and able to comply with the scheduled radiographic evaluations and the prescribed treatment and rehabilitation.
You may not qualify if:
- A potential subject who meets the following criterion will be excluded from participation in this study:
- Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
- Patients with a scaphoid fracture at the ipsilateral side in medical history
- Pregnancy.
- Phase II - Follow-up phase
- In order to be eligible to participate in Phase II of the study, a subject must meet all of the following criteria:
- Patients who completed Phase I of the study and have a radiographically confirmed scaphoid fracture on CT or HR-pQCT.
- Conservatively treated scaphoid fractures.
- A potential subject who meets the following criterion will be excluded from participation in this study:
- Patients, who as judged by the principal investigator, are mentally compromised or are unlikely to be compliant with the follow-up evaluations schedule.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VieCuri Medical Centre
Venlo, Limburg, 5912, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heinrich Janzing, MD, PhD
VieCuri MC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 20, 2017
First Posted
April 2, 2019
Study Start
December 12, 2017
Primary Completion
November 28, 2019
Study Completion
April 28, 2020
Last Updated
April 2, 2019
Record last verified: 2019-03